Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tai

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Nature. Mental Health|June 15, 2026
Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosisMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Brain Communications|October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanismsMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
The Journal of Experimental Medicine|February 25, 2009
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36Terry K Means, Eleftherios Mylonakis, Emmanouil Tampakakis, et al.
Journal of Molecular Biology|May 14, 2003
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitorsBradley A Katz, Kyle Elrod, Erik Verner, et al.
Gynecologic Oncology|October 8, 2011
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerAlan N Gordon, Michael Teneriello, Mike F Janicek, et al.
British Journal of Haematology|December 23, 2016
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myelomaNoopur S Raje, Philippe Moreau, Evangelos Terpos, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2006
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitorsDavid Sperandio, Vincent W-F Tai, Julia Lohman, et al.
Brain : a Journal of Neurology|June 13, 2025
Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's diseaseVictor S Hvingelby, Miriam Højholt Terkelsen, Erik L Johnsen, et al.
Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.
Annals of Neurology|April 27, 2005
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1Raquel Ros, Pilar Gómez Garre, Michio Hirano, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Nature. Mental Health|June 15, 2026
Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosisMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Brain Communications|October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanismsMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
The Journal of Experimental Medicine|February 25, 2009
Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36Terry K Means, Eleftherios Mylonakis, Emmanouil Tampakakis, et al.
Journal of Molecular Biology|May 14, 2003
Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitorsBradley A Katz, Kyle Elrod, Erik Verner, et al.
Gynecologic Oncology|October 8, 2011
Phase III trial of induction gemcitabine or paclitaxel plus carboplatin followed by paclitaxel consolidation in ovarian cancerAlan N Gordon, Michael Teneriello, Mike F Janicek, et al.
British Journal of Haematology|December 23, 2016
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myelomaNoopur S Raje, Philippe Moreau, Evangelos Terpos, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2006
Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitorsDavid Sperandio, Vincent W-F Tai, Julia Lohman, et al.
Brain : a Journal of Neurology|June 13, 2025
Cholinergic patterns correlate with dopamine medication ON freezing of gait in Parkinson's diseaseVictor S Hvingelby, Miriam Højholt Terkelsen, Erik L Johnsen, et al.
Journal of Medicinal Chemistry|February 15, 2019
Design of N-Benzoxaborole Benzofuran GSK8175-Optimization of Human Pharmacokinetics Inspired by Metabolites of a Failed Clinical HCV InhibitorPek Y Chong, J Brad Shotwell, John Miller, et al.
Annals of Neurology|April 27, 2005
Genetic linkage of autosomal dominant progressive supranuclear palsy to 1q31.1Raquel Ros, Pilar Gómez Garre, Michio Hirano, et al.
Pageof 10